Tag: PLHIV

People Living With HIV Worried Over Expired ARVs…MCAZ Calls For Calm

Michael Gwarisa

PEOPLE living with HIV (PLHIV) have expressed concerns over failure by government and the Medicines Control Authority of Zimbabwe (MCAZ) to consult with them following the expiration of Antiretroviral (ARV) drugs. By Michael Gwarisa The development follows revelations that health institutions continued dispensing ARVs even after they had passed their shelf life. This has not  gone down well with PLHIV and on ART who  believe the consultation process should have started with them since they are the ones directly affected by any changes in the drugs. Speaking to HealthTimes, Mrs…

Pin
Share20
Tweet
20 Shares
Share
Read More

ARVs Crisis Deepens…PLHIV Seek Audience With Finance Minister

NewsRoom

PEOPLE living with HIV (PLHIV) will soon be engaging the Ministry of Finance and Economic Development  to plead with government to allocate  foreign currency for procuring Anti Retro Viral Drugs (ARVs), amidst indications that the National Aids Council (NAC) is struggling to make purchases since suppliers are demanding foreign currency. By Michael Gwarisa Indications on the ground show that procurement of ARVs medicines has of late been a Sisyphean task at the back of  NAC’s failure to convert the US$ 20 million in RTGS or bond notes stuck in their…

Pin
Share37
Tweet
37 Shares
Share
Read More

MSF Pilots New ART Dispensing Model In Mwenezi

NewsRoom

MEDECINS Sans Frontiers in Zimbabwe (MSF), has launched a new system of administering Antiretroviral Therapy (ART) drugs in Mwenezi, Masvingo in a bid to increase ART adherence, amidst indications that many ART clients were now defaulting on their medications due to the long distance and inaccessibility of health facilities. By Michael Gwarisa recently in Sovelela, Mwenezi The new ART administering method dubbed Out of Facility Community ART Distribution (OFCAD),  is an outreach strategy whereby patients no longer need to visit a health care facility to access ART but rather the…

Pin
Share51
Tweet
51 Shares
Share
Read More